Rosetta Genomics Interpace Diagnostics Q3 Revenues Up 38 Percent The company beat the consensus Wall Street estimate on the top line and guided to 2018 revenues of between $21 million and $22 million. Rosetta Genomics Files for Chapter 7 Bankruptcy Rosetta had disclosed that it intended to file for bankruptcy after its merger with Genoptix was not completed as planned. Rosetta Genomics Dispute With Genoptix Places Pending Merger in Jeopardy The merger, which was previously scuttled and later revived with Rosetta shareholder approval, was due to close on May 27. Rosetta Genomics Shareholders Approve Genoptix Merger Upon completion of the transaction, Rosetta will become a privately held subsidiary of Genoptix and its shares will cease to trade on the Nasdaq. Genoptix Inks Distribution Deal for Rosetta Genomics' Testing Services The deal comes as the firms try — for the second time — to close a merger that had previously failed to gain necessary approval from Rosetta shareholders. Feb 28, 2018 Rosetta Genomics, Genoptix Sign New Merger Agreement Feb 23, 2018 Rosetta Genomics, Genoptix Merger Terminated Dec 15, 2017 Genoptix to Acquire Rosetta Genomics for $10M Nov 30, 2017 Rosetta Genomics Receives Nasdaq Non-Compliance Letter Nov 8, 2017 Rosetta Genomics Receives Notification of Nasdaq Non-Compliance Oct 10, 2017 Rosetta Genomics Q2 Revenues Jump on Sales of Thyroid Assay Sep 28, 2017 Rosetta Genomics Initiates $2M Private Placement Sep 8, 2017 Rosetta Genomics Inks Deal to Sell PersonalizeDx for $2.9M Sep 5, 2017 Rosetta Genomics Announces Layoffs Aug 4, 2017 Rosetta Genomics Prices $2.7M Securities Offering May 23, 2017 Rosetta Genomics, Meir Medical Partner on microRNA Biomarker Study May 22, 2017 Rosetta Genomics Plans to Sell PersonalizeDx Business May 5, 2017 Rosetta Genomics Signs Brazilian Distribution Pact for Thyroid Test May 4, 2017 NYS Gives Final Approval for Rosetta Genomics' Thyroid Cancer Test May 2, 2017 Rosetta Genomics Realigns Strategy to Focus on Thyroid Test Mar 30, 2017 Rosetta Genomics Q4 Revenues Drop 44 Percent Mar 16, 2017 Rosetta Genomics Announces Reverse Stock Split Feb 23, 2017 Rosetta Genomics Completes Private Placement Tranche Feb 8, 2017 Rosetta Genomics Reports Q4 Sales Growth for Thyroid Nodule Test Dec 20, 2016 Rosetta Genomics Q3 Revenues Down 10 Percent Load More Breaking News Epic Sciences, Biosplice Therapeutics Partner on Multiomic Profiling for Cancer Trials Hamilton, Pacific Biosciences Partner on Automating DNA Sample Prep Danaher Q4 Revenues Rise 21 Percent COVID-19 Severity Biomarker Candidates Revealed in RNA Sequencing Study Flatiron Health, Japanese Hospital Partner on Real-World GI Cancer Database Abbott Q4 Diagnostics Revenues Grow 3 Percent, Full-Year Revenues up 25 Percent The Scan Polarized Science Confidence A new survey finds that confidence in science among US adults is increasingly polarized, the Associated Press says. Time to Sit Back and Relax NPR reports that the US National Institutes of Health has transferred the last of its eligible former research chimpanzees to a sanctuary. Omicron-Focused Vaccines The New York Times reports both Pfizer-BioNTech and Moderna have launched trials of SARS-CoV-2 vaccines targeting the Omicron variant. Nature Papers Present Cloud-Computing Analysis Approach, Transcription Factor With Role in Bacterial Genome Organization In Nature this week: researchers describe the free, open-source cloud-computing infrastructure Serratus and more.